journal article·2019-12-04Open access

Gold nanoparticles and hepatitis B virus

Babak Negahdari, Mohammad Darvishi, Ali Asghar Saeedi

Abstract

Hepatitis B virus (HBV) infection is one of the major health issues in the world presently with high tendency of leading to hepatocarcinoma, cirrhosis, and liver cancer, especially if not properly managed. It has been estimated that there are about 2 billion people with a serological profile of HBV infection, and 360 million patients worldwide living with chronic HBV-associated liver disease, hence the need to find an efficient and precise diagnosis technique to drive a robust treatment for Hepatitis B virus cannot be over emphasized. The emergence of analytical device like biosensor which combines biological and physicochemical element to detect HBV in screened samples has been very helpful in providing a timely intervention to tame this virus. This review focuses on the current state of biosensor researches with respect to various in-depth application of gold nanoparticle for the detection of hepatitis B virus (HBV).
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Advanced biosensing and bioanalysis techniques · SARS-CoV-2 and COVID-19 Research · SARS-CoV-2 detection and testing

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences

Imam Khomeini Hospital Complex, Neuroscience Institute, Tehran University of Medical Sciences

lnfectious Diseases and Tropical Medicine Research Center (IDTMRC), AJA University of Medical Sciences

References (66)

Show source-provided references
1. 10.1093/epirev/mxj00910.1093/epirev/mxj009 ↗
2. 10.1016/S1872-2040(11)60541-010.1016/S1872-2040(11)60541-0 ↗
3. Karayiannis P, Novick DM, Lok ASF, et al. Hepatitis B virus DNA in saliva, urine, and seminal fluid of carriers of hepatitis Beantigen. Br Med J (Clin Res Ed). 1985;290:1853.
4. 10.1093/clinchem/43.8.150010.1093/clinchem/43.8.1500 ↗
5. 10.1002/1097-0142(19880515)61:10<1942::AID-CNCR2820611003>3.0.CO;2-J10.1002/1097-0142(19880515)61:10<1942::AID-CNCR2820611003>3.0.CO;2-J ↗
6. Mahmoudvand H, Taee N, Goodarzi FM. Prevalence and risk factors of intestinal protozoan infections in children (2-15 yr old) from Lorestan Province, western Iran. Trop Biomed. 2018;35:259–266.
7. Gharib A, Forootan M, Sharifzadeh M, et al. Diagnostic efficacy of 24-hr esophageal pH monitoring in patients with refractory gastroesophageal reflux disease. Open access Maced. J Med Sci. 2018;6:1235.
8. 10.1016/S1367-5931(98)80087-210.1016/S1367-5931(98)80087-2 ↗
9. 10.2147/nano.2006.1.4.43310.2147/nano.2006.1.4.433 ↗
10. 10.1016/j.aca.2006.10.00310.1016/j.aca.2006.10.003 ↗
11. 10.1039/C2AN36099C10.1039/C2AN36099C ↗
12. Sherkatolabbasieh HR, Taee N, Shafizadeh S. Bilateral parotiditis as the first presentation of HIV infection. Iran J Pediatr 2014;24(S2):S41.
13. Sasaki T, Tahira T, Suzuki A, et al. Precise estimation of allele frequencies of single-nucleotide polymorphisms by a quantitative SSCP analysis of pooled DNA. Am J. 2001;68(1):214–218.
14. 10.1007/s00439000039610.1007/s004390000396 ↗
15. 10.1016/j.jconrel.2009.12.00610.1016/j.jconrel.2009.12.006 ↗
16. 10.1126/science.277.5329.107810.1126/science.277.5329.1078 ↗
17. 10.1126/science.289.5485.175710.1126/science.289.5485.1757 ↗
18. 10.1021/jp050728810.1021/jp0507288 ↗
19. 10.1021/ja711298b10.1021/ja711298b ↗
20. 10.1021/ja057018010.1021/ja0570180 ↗
21. 10.1002/anie.20080323810.1002/anie.200803238 ↗
22. Gh S, Firouzi M, Mahdavifard S. Phototherapy motivates protein and lipid oxidation in jaundiced term and late term neonates. Casp J Pediatr Sep. 2017;3:248–252.
23. 10.1002/chem.20070185010.1002/chem.200701850 ↗
24. Moradniani M, Firouzi M, Jaferian S, et al. A randomized clinical trial; comparing levofloxacin based sequential and clarithromycin based sequential versus triple therapy for Helicobacter pylori eradication. Med Sci. 2018;22:134–139.
25. 10.1016/j.bios.2010.06.06710.1016/j.bios.2010.06.067 ↗
26. 10.1002/chem.20080181210.1002/chem.200801812 ↗
27. 10.1021/ac03425610.1021/ac034256 ↗
28. 10.1111/and.1293210.1111/and.12932 ↗
29. 10.1016/j.bios.2010.07.12110.1016/j.bios.2010.07.121 ↗
30. Darvishi M, Hajiparvaneh R, Mohammadi M, et al. Barriers and motivators factors effecting influenza vaccination uptake among healthcare workers. Med Sci J Islam Azad Univesity-Tehran Med Branch. 2017;27:217–221.
31. Firouzi M, Yazdanmehr R, Eliasy H, et al. The prevalence of the ABO hemolytic disease of the newborn and its complications in an Iranian population. Iran J Pediatr Hematol Oncol. 2018;8:37–47.
32. Hormozi SF, Vasei N, Aminianfar M, et al. Antibiotic resistance in patients suffering from nosocomial infections in Besat Hospital. Eur. J. Transl. Myol 2018;28(3):7594.10.4081/ejtm.2018.7594 ↗
33. Darvishi M, Aminianfar M, Heidarinia B, et al. Knowledge and awareness regarding viral hepatitis among paramedical and humanities students. J Biostat Epidemiol. 2018;3:60–64.
34. 10.1021/la049463z10.1021/la049463z ↗
35. 10.1016/j.colsurfa.2005.11.06210.1016/j.colsurfa.2005.11.062 ↗
36. 10.1097/MD.000000000001056510.1097/MD.0000000000010565 ↗
37. 10.1007/s00604-011-0585-410.1007/s00604-011-0585-4 ↗
38. 10.1016/j.bios.2009.08.04810.1016/j.bios.2009.08.048 ↗
39. 10.3748/wjg.v20.i35.1248510.3748/wjg.v20.i35.12485 ↗
40. 10.1016/j.snb.2010.08.01310.1016/j.snb.2010.08.013 ↗
41. 10.1016/j.bios.2009.04.00910.1016/j.bios.2009.04.009 ↗
42. 10.1016/j.snb.2005.03.05510.1016/j.snb.2005.03.055 ↗
43. 10.1016/j.snb.2006.12.04010.1016/j.snb.2006.12.040 ↗
44. 10.1016/j.snb.2008.06.02010.1016/j.snb.2008.06.020 ↗
45. 10.1016/j.bios.2007.09.00310.1016/j.bios.2007.09.003 ↗
46. Huang C Huang Y Lin T et al. An integrated microcantilever-based wireless DNA chip for hepatitis B virus (HBV) DNA detection. 15th International Conference on Miniaturized Systems for Chemistry and Life Sciences; 2011 October 2–6; Seattle WA. doi:10.978-0-9798064-4-5/
47. 10.1016/j.bios.2009.06.01510.1016/j.bios.2009.06.015 ↗
48. 10.1016/j.bios.2011.11.03710.1016/j.bios.2011.11.037 ↗
49. 10.3390/s12020165710.3390/s120201657 ↗
50. 10.1016/j.bios.2010.06.05010.1016/j.bios.2010.06.050 ↗
51. 10.1016/j.bios.2009.12.00210.1016/j.bios.2009.12.002 ↗
52. Li J, Deng T, Chu X, et al. Rolling circle amplification combined with gold nanoparticle aggregates for highly sensitive identification of single-nucleotide polymorphisms. Anal Chem. 2010;82(7):2811–2816.
53. 10.1016/j.clinbiochem.2010.07.00110.1016/j.clinbiochem.2010.07.001 ↗
54. 10.1186/1477-3155-8-510.1186/1477-3155-8-5 ↗
55. 10.1007/s00216-011-5489-y10.1007/s00216-011-5489-y ↗
56. 10.1021/ac103283p10.1021/ac103283p ↗
57. Munge BS, Coffey AL, Doucette JM, et al. Nanostructured immunosensor for attomolar detection of cancer biomarker interleukin-8 using massively labeled superparamagnetic particles. Angew Chemie Int Ed. 2011;50(34):7915–7918.
58. 10.1039/c0cp01755h10.1039/c0cp01755h ↗
59. 10.1016/j.bios.2010.03.02510.1016/j.bios.2010.03.025 ↗
60. 10.1016/j.bios.2010.07.06910.1016/j.bios.2010.07.069 ↗
61. 10.1021/ac100563t10.1021/ac100563t ↗
62. 10.1021/nl100008610.1021/nl1000086 ↗
63. 10.1016/j.biomaterials.2010.01.13610.1016/j.biomaterials.2010.01.136 ↗
64. 10.1016/j.biomaterials.2009.12.00710.1016/j.biomaterials.2009.12.007 ↗
65. 10.1088/0957-4484/19/31/31510210.1088/0957-4484/19/31/315102 ↗
66. 10.1016/j.aca.2010.04.02710.1016/j.aca.2010.04.027 ↗